Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

Oxford skyline © John Cairns

The systematic review, published in the journal JAMA Psychiatry, looked at 24 studies which covered more than 50,000 people with schizophrenia across 15 countries over four decades.

Professor Seena Fazel of Oxford’s Department of Psychiatry said: 'The perception that schizophrenia is associated with violent behaviour attracts considerable media attention and occasionally misleading headlines. This systematic review clarifies that there is now robust evidence from 24 individual studies of a modest increased risk of perpetration of violence in people with schizophrenia, but it provides the necessary context – that over a period of around four decades, this amounts to no more than 1 in 4 men and 1 in 10 women with schizophrenia for serious violent outcomes.

'This provides clinicians with an important target for prevention of violent acts by patients who may be at elevated risk, as well as helping to reduce stigma in people with schizophrenia and related disorders.'

The researchers also found that other factors such as the misuse of drugs and alcohol contributed to a doubling of violence perpetration risk in women and men with schizophrenia, which the researchers highlight as a target for prevention of such behaviour, as well as demonstrating the importance of provision of healthcare services to tackle substance misuse.

Read the full story on the University of Oxford website. 

Similar stories

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.